In glioblastoma, the mutations alter EGFR dimer formation, attenuating ligand bias, corrupting downstream signaling.408 Mutations that alter the transcriptional landscapes, perturb the protein interactome,409,410 increase cancer heterogeneity and aggressiveness. Here, EGFR is linked to cancer.